Trypanosoma cruzi: desferrioxamine decreases mortality and parasitemia in infected mice through a trypanostatic effect.

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.creatorArantes, Jerusa Marilda-
Autor(es): dc.creatorFrancisco, Amanda Fortes-
Autor(es): dc.creatorVieira, Paula Melo de Abreu-
Autor(es): dc.creatorSilva, Maísa-
Autor(es): dc.creatorAraújo, Márcio Sobreira Silva-
Autor(es): dc.creatorCarvalho, Andréa Teixeira de-
Autor(es): dc.creatorPedrosa, Maria Lúcia-
Autor(es): dc.creatorCarneiro, Cláudia Martins-
Autor(es): dc.creatorTafuri, Washington Luiz-
Autor(es): dc.creatorMartins Filho, Olindo Assis-
Autor(es): dc.creatorSantos, Silvana Maria Elói-
Data de aceite: dc.date.accessioned2019-11-06T13:24:58Z-
Data de disponibilização: dc.date.available2019-11-06T13:24:58Z-
Data de envio: dc.date.issued2012-09-12-
Data de envio: dc.date.issued2012-09-12-
Data de envio: dc.date.issued2011-
Fonte completa do material: dc.identifierhttp://hdl.handle.net/123456789/1383-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/capes/554918-
Descrição: dc.descriptionDesferrioxamine (DFO) is a potent iron chelator that is also known to modulate inflammation and act as an efficient antioxidant under normal conditions and under oxidative stress. Many in vitro and in vivo studies have shown the efficacy of DFO in the treatment of viral, bacterial and protozoan infections. DFO is known to reduce the intensity of Trypanosoma cruzi infections in mice even during a course of therapy that is not effective in maintaining anaemia or low iron levels. To further clarify these findings, we investigated the action of DFO on mouse T. cruzi infection outcomes and the direct impact of DFO on parasites. Infected animals treated with DFO (5 mg/animal/day) for 35 days, beginning 14 days prior to infection, presented lower parasitemia and lower cumulative mortality rate. No significant effect was observed on iron metabolism markers, erythrograms, leukograms or lymphocyte subsets. In the rapid method for testing in vivo T. cruzi susceptibility, DFO also induced lower parasitemia. In regard to its direct impact on parasites, DFO slightly inhibited the growth of amastigotes and trypomastigotes in fibroblast culture. Trypan blue staining showed no effects of DFO on parasite viability, and only minor apoptosis in trypomastigotes was observed. Nevertheless, a clear decrease in parasite mobility was detected. In conclusion, the beneficial actions of DFO on mice T. cruzi infection seem to be independent of host iron metabolism and free of significant haematological side effects. Through direct action on the parasite, DFO has more effective trypanostatic than trypanocidal properties.-
Idioma: dc.languageen-
Direitos: dc.rightsO Periódico Experimental Parasitology concede permissão para depósito deste artigo no Repositório Institucional da UFOP. Número da licença: 3280851340833.-
Palavras-chave: dc.subjectTrypanosoma cruzi-
Palavras-chave: dc.subjectDesferrioxamine (DFO)-
Palavras-chave: dc.subjectEtiological treatment-
Palavras-chave: dc.subjectExperimental infection-
Palavras-chave: dc.subjectTrypanostatic effect-
Título: dc.titleTrypanosoma cruzi: desferrioxamine decreases mortality and parasitemia in infected mice through a trypanostatic effect.-
Aparece nas coleções:Repositório Institucional - UFOP

Não existem arquivos associados a este item.